Precigen 41st JPM Healthcare Presentation_11 january 2023.pdf

1、 Precigen.All rights reserved.Precigen,Inc.January 11,2023January 11,2023Helen Sabzevari,PhDPresident&Chief Executive Officer41stAnnual J.P.Morgan Healthcare Conference Precigen.All rights reserved.Forward-looking Statements2Some of the statements made in this presentation are forward-looking statem

2、ents.These forward-looking statements are based uponthe Companys current expectations and projections about future events and generally relate to plans,objectives,and expectations for the development of the Companys business,including the timing and progress of preclinical studies,clinical trials,di

3、scovery programs and related milestones,the promise of the Companys portfolio of therapies,and in particular its CAR-T and AdenoVerse therapies.Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable,all forward-looking

4、statements involve risks and uncertainties,including the possibility that the timeline for the Companys clinical trials might be impacted by the COVID-19 pandemic,and actual future results may be materially different from the plans,objectives and expectations expressed in this presentation.The Compa

5、ny has no obligation to provide any updates to these forward-looking statements even if its expectations change.All forward-looking statements are expressly qualified in their entirety by this cautionary statement.For further information on potential risks and uncertainties,and other important facto

6、rs,any of which could cause the Companys actual results to differ from those contained in the forward-looking statements,see the section entitled Risk Factors in the Companys most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission.This presenta